BioStem Technologies, Inc. (OTC: BSEM), a leading MedTech company specializing in placental-derived biologics for advanced wound care, today announced the launch of a new product line, American Amnion ...
Sustained response seen up to 6 months after injection. (HealthDay News) — Injected micronized amnion/chorion bilayer (AC) product significantly reduces time to symptom relief in patients with ...
Dermacyte AC Matrix, a Lyophilized Amnion Chorion Membrane Allograft, utilizes an optimized bioprocess for graft preservation and reabsorption. As opposed to dehydrated products on the market, the ...
MARIETTA, Ga., June 15, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, ...
Head-to-head study comparing BioREtain®- processed Amnion Chorion (BR-AC) allograft to standard of care initiated in Q4 2024 to demonstrate healing superiority Topline results and full data analysis ...
The fetal membranes consist of the chorion, amnion, yolk sac, and allantois. The chorion has three layers: cytotrophoblastic, chorionic connective tissue, and basement membrane. The chorion lies ...
Intrauterine infection has been frequently linked with preterm labor before 30 wk of human pregnancy. Many different species of organisms have been detected, leading to the suggestion that ...
Merakris to showcase new Lyophilized Amnion Chorion Allograft at the Fall Symposium for Advanced Wound Care (SAWC) in Las Vegas at booth 440 on October 2-5, 2024. RESEARCH TRIANGLE PARK, N.C., Oct. 01 ...
POMPANO BEACH, Fla., June 23, 2025 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (“BioStem” or the “Company”) (OTC: BSEM), a leading MedTech company focused on the development, manufacturing, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback